What does Lifeline Biotechnologies, Inc. do?

Jun 22 2025 06:27 PM IST
share
Share Via
Lifeline Biotechnologies, Inc. operates in the Medical Specialties industry with a market capitalization of USD 25.1 billion. As of June 2019, it reported a net profit of USD 0 million.
Overview:
Lifeline Biotechnologies, Inc. operates in the Medical Specialties industry and has a market capitalization of USD 25,098.28 Million.

Financial Snapshot:
Most recent Net Profit: 0 Million (Quarterly Results - Jun 2019)
Market-cap: USD 25,098.28 Million
Category: Medical Specialties

Key Metrics:
P/E: 25,098.00
Debt Equity: 0.31
Return on Equity: 0.20%
Price to Book: 198.06

Contact Details:
Details: No Company Details Available
Registrar Address: Not available.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News